Richard Scott Struthers
CIK: 0001746298
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (43 total)
- Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect110K shares at avg. $85.00$9.3M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Direct176.7K shares at avg. $85.00$15.0M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect80K shares at avg. $85.00$6.8M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect111.1K shares at avg. $85.00$9.4M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect111.1K shares at avg. $85.00$9.4M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect106K shares at avg. $85.00$9.0M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect111.1K shares at avg. $85.00$9.4M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect1K shares at avg. $85.00$85K - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect136.8K shares at avg. $85.00$11.6M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect111.1K shares at avg. $85.00$9.4M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Indirect100K shares at avg. $85.00$8.5M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Disposition(D)Direct248K shares at avg. $85.00$21.1M - Aug 7, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Exercise(M)Direct4K shares at avg. $25.19$100K - Aug 7, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Exercise(M)Direct4.4K shares at avg. $22.61$100K - Aug 7, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Exercise(M)Direct6.5K shares at avg. $15.29$100K - Aug 7, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Exercise(M)Direct5K shares at avg. $20.02$100K - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Indirect111.1K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Indirect222.2K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Indirect222.2K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Indirect80K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Direct222.2K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Indirect222.2K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Indirect80K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Direct111.1K shares- - May 29, 2026CRNX
Crinetics Pharmaceuticals, Inc.
Gift(G)Direct111.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 110,000 | $85.00 | $9,350,000 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 176,663 | $85.00 | $15,016,355 | Direct |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 80,000 | $85.00 | $6,800,000 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 111,100 | $85.00 | $9,443,500 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 111,100 | $85.00 | $9,443,500 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 106,000 | $85.00 | $9,010,000 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 111,100 | $85.00 | $9,443,500 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 1,000 | $85.00 | $85,000 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 136,805 | $85.00 | $11,628,425 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 111,100 | $85.00 | $9,443,500 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 100,000 | $85.00 | $8,500,000 | Indirect |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition(D) | 248,043 | $85.00 | $21,083,655 | Direct |
| Aug 7, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise(M) | 3,969 | $25.19 | $99,979 | Direct |
| Aug 7, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise(M) | 4,422 | $22.61 | $99,981 | Direct |
| Aug 7, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise(M) | 6,542 | $15.29 | $100,027 | Direct |
| Aug 7, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Exercise(M) | 4,995 | $20.02 | $100,000 | Direct |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 111,100 | - | $0 | Indirect |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 222,200 | - | $0 | Indirect |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 222,200 | - | $0 | Indirect |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 80,000 | - | $0 | Indirect |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 222,200 | - | $0 | Direct |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 222,200 | - | $0 | Indirect |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 80,000 | - | $0 | Indirect |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 111,100 | - | $0 | Direct |
| May 29, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Gift(G) | 111,100 | - | $0 | Direct |
1-25 of 43 transactions
About Struthers Richard Scott
Struthers Richard Scott (SEC CIK 0001746298) files insider reports with the SEC as Director of Frazier Life Sciences Acquisition Corp. II (FLSC) and President & CEO of Crinetics Pharmaceuticals, Inc. (CRNX).
Signal8 holds 13 ownership filings by Struthers Richard Scott (1 Form 3, 12 Form 4), filed between Dec 4, 2024 and Oct 13, 2026. Those filings report 43 transactions, from Dec 2, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Struthers Richard Scott's filings is in PALO ALTO, CA.
Recent filings by Struthers Richard Scott
Other insiders filing for Frazier Life Sciences Acquisition Corp. II (FLSC)
- Cha Albert, Chief Executive Officer
- Li Kevin, Chief Business Officer
- Adams Francis Sherman, Chief Financial Officer
- Palleiko Benjamin L, Director
- Jackson Alexandra, General Counsel
- Fairey William, Director